Disney issues scathing response to Scarlett Johansson's Black Widow lawsuit
Disney blasted the breach of contract lawsuit filed against the company by Scarlett Johansson on Thursday, saying it has "no merit whatsoever" and is "especially sad and distressing in its callous disregard for the horrific and prolonged global effects of the COVID-19 pandemic."
In her suit, Johansson says that because Disney released her Marvel film Black Widow in theaters and streaming on Disney+ at the same time, she lost out on millions in backend compensation; a person familiar with the terms of Johansson's contract told The Wall Street Journal this move cost her more than $50 million.
Disney disagreed, saying in its statement that the company "has fully complied with Ms. Johansson's contract and furthermore, the release of Black Widow on Disney+ with Premier Access has significantly enhanced her ability to earn additional compensation on top of the $20 million she has received to date."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Black Widow's release was delayed several times because of the pandemic, and it finally hit theaters and Disney+ on July 9. Through ticket and streaming sales, Black Widow has made more than $319 million globally, which is on the low end for a Marvel movie.
In a statement to Variety, Johansson's lawyer John Berlinski said it's "no secret that Disney is releasing films like Black Widow directly onto Disney+ to increase subscribers and thereby boost the company's stock price — and that it's hiding behind COVID-19 as a pretext to do so. But ignoring the contracts of the artists responsible for the success of its films in furtherance of this short-sighted strategy violates their rights and we can look forward to proving as much in court."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
‘Lumpy skin’ protests intensify across France as farmers fight cullIN THE SPOTLIGHT A bovine outbreak coupled with ongoing governmental frustrations is causing major problems for French civil society
-
The best books of 2025The Week Recommends A deep dive into the site of a mass shooting, a new release from the author of ‘Atonement’ and more
-
Inside Minnesota’s extensive fraud schemesThe Explainer The fraud allegedly goes back to the Covid-19 pandemic
-
TikTok secures deal to remain in USSpeed Read ByteDance will form a US version of the popular video-sharing platform
-
Unemployment rate ticks up amid fall job lossesSpeed Read Data released by the Commerce Department indicates ‘one of the weakest American labor markets in years’
-
US mints final penny after 232-year runSpeed Read Production of the one-cent coin has ended
-
Warner Bros. explores sale amid Paramount bidsSpeed Read The media giant, home to HBO and DC Studios, has received interest from multiple buying parties
-
Gold tops $4K per ounce, signaling financial uneaseSpeed Read Investors are worried about President Donald Trump’s trade war
-
Electronic Arts to go private in record $55B dealspeed read The video game giant is behind ‘The Sims’ and ‘Madden NFL’
-
New York court tosses Trump's $500M fraud fineSpeed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in IntelSpeed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
